nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—DRD2—nicotine dependence	0.789	1	CbGaD
Thioridazine—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00466	0.117	CcSEcCtD
Thioridazine—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00321	0.0804	CcSEcCtD
Thioridazine—Abnormal dreams—Varenicline—nicotine dependence	0.00239	0.0599	CcSEcCtD
Thioridazine—Lethargy—Varenicline—nicotine dependence	0.00179	0.0449	CcSEcCtD
Thioridazine—CHRM2—cardiovascular system—nicotine dependence	0.00174	0.0584	CbGeAlD
Thioridazine—Psychotic disorder—Varenicline—nicotine dependence	0.00171	0.0429	CcSEcCtD
Thioridazine—DRD1—midbrain—nicotine dependence	0.00169	0.0566	CbGeAlD
Thioridazine—Asthma—Varenicline—nicotine dependence	0.00152	0.038	CcSEcCtD
Thioridazine—HTR6—brain—nicotine dependence	0.00143	0.0478	CbGeAlD
Thioridazine—HTR1A—cardiovascular system—nicotine dependence	0.00141	0.0474	CbGeAlD
Thioridazine—Photosensitivity reaction—Varenicline—nicotine dependence	0.00138	0.0347	CcSEcCtD
Thioridazine—Weight increased—Varenicline—nicotine dependence	0.00138	0.0346	CcSEcCtD
Thioridazine—HTR7—cardiovascular system—nicotine dependence	0.00135	0.0453	CbGeAlD
Thioridazine—HTR2C—midbrain—nicotine dependence	0.00131	0.044	CbGeAlD
Thioridazine—ADRA1A—cardiovascular system—nicotine dependence	0.0013	0.0437	CbGeAlD
Thioridazine—KCNH2—cardiovascular system—nicotine dependence	0.00126	0.0422	CbGeAlD
Thioridazine—Oedema peripheral—Varenicline—nicotine dependence	0.0012	0.03	CcSEcCtD
Thioridazine—ADRA1B—brain—nicotine dependence	0.00114	0.0382	CbGeAlD
Thioridazine—HTR1A—midbrain—nicotine dependence	0.0011	0.037	CbGeAlD
Thioridazine—Arrhythmia—Varenicline—nicotine dependence	0.00108	0.0272	CcSEcCtD
Thioridazine—Mental disorder—Varenicline—nicotine dependence	0.00106	0.0266	CcSEcCtD
Thioridazine—DRD1—brain—nicotine dependence	0.00106	0.0356	CbGeAlD
Thioridazine—Erythema—Varenicline—nicotine dependence	0.00106	0.0265	CcSEcCtD
Thioridazine—HTR7—midbrain—nicotine dependence	0.00105	0.0354	CbGeAlD
Thioridazine—CYP2C9—cardiovascular system—nicotine dependence	0.00102	0.0343	CbGeAlD
Thioridazine—DRD2—midbrain—nicotine dependence	0.000997	0.0334	CbGeAlD
Thioridazine—Vision blurred—Varenicline—nicotine dependence	0.000996	0.025	CcSEcCtD
Thioridazine—Tremor—Varenicline—nicotine dependence	0.00099	0.0248	CcSEcCtD
Thioridazine—KCNH2—midbrain—nicotine dependence	0.000983	0.0329	CbGeAlD
Thioridazine—Anaemia—Varenicline—nicotine dependence	0.000977	0.0245	CcSEcCtD
Thioridazine—Agitation—Varenicline—nicotine dependence	0.000971	0.0243	CcSEcCtD
Thioridazine—CYP2E1—cardiovascular system—nicotine dependence	0.000969	0.0325	CbGeAlD
Thioridazine—Angioedema—Varenicline—nicotine dependence	0.000966	0.0242	CcSEcCtD
Thioridazine—Acetophenazine—DRD2—nicotine dependence	0.000919	0.116	CrCbGaD
Thioridazine—Oedema—Varenicline—nicotine dependence	0.000862	0.0216	CcSEcCtD
Thioridazine—CHRM2—brain—nicotine dependence	0.000855	0.0287	CbGeAlD
Thioridazine—Thrombocytopenia—Varenicline—nicotine dependence	0.000844	0.0212	CcSEcCtD
Thioridazine—HTR2A—cardiovascular system—nicotine dependence	0.000842	0.0282	CbGeAlD
Thioridazine—Tachycardia—Varenicline—nicotine dependence	0.000842	0.0211	CcSEcCtD
Thioridazine—Hyperhidrosis—Varenicline—nicotine dependence	0.000834	0.0209	CcSEcCtD
Thioridazine—HTR2C—brain—nicotine dependence	0.000824	0.0276	CbGeAlD
Thioridazine—Anorexia—Varenicline—nicotine dependence	0.000822	0.0206	CcSEcCtD
Thioridazine—Hypotension—Varenicline—nicotine dependence	0.000806	0.0202	CcSEcCtD
Thioridazine—ADRA2A—midbrain—nicotine dependence	0.000774	0.0259	CbGeAlD
Thioridazine—Somnolence—Varenicline—nicotine dependence	0.000767	0.0192	CcSEcCtD
Thioridazine—Decreased appetite—Varenicline—nicotine dependence	0.00075	0.0188	CcSEcCtD
Thioridazine—Constipation—Varenicline—nicotine dependence	0.000738	0.0185	CcSEcCtD
Thioridazine—Feeling abnormal—Varenicline—nicotine dependence	0.000711	0.0178	CcSEcCtD
Thioridazine—HTR1A—brain—nicotine dependence	0.000694	0.0233	CbGeAlD
Thioridazine—Body temperature increased—Varenicline—nicotine dependence	0.000682	0.0171	CcSEcCtD
Thioridazine—HTR7—brain—nicotine dependence	0.000663	0.0222	CbGeAlD
Thioridazine—HTR2A—midbrain—nicotine dependence	0.000658	0.0221	CbGeAlD
Thioridazine—ADRA1A—brain—nicotine dependence	0.000639	0.0214	CbGeAlD
Thioridazine—Hypersensitivity—Varenicline—nicotine dependence	0.000635	0.0159	CcSEcCtD
Thioridazine—DRD2—brain—nicotine dependence	0.000627	0.021	CbGeAlD
Thioridazine—KCNH2—brain—nicotine dependence	0.000617	0.0207	CbGeAlD
Thioridazine—Diarrhoea—Varenicline—nicotine dependence	0.00059	0.0148	CcSEcCtD
Thioridazine—Zuclopenthixol—DRD2—nicotine dependence	0.000581	0.0736	CrCbGaD
Thioridazine—CYP2C8—brain—nicotine dependence	0.000565	0.0189	CbGeAlD
Thioridazine—Triflupromazine—DRD2—nicotine dependence	0.000563	0.0713	CrCbGaD
Thioridazine—Vomiting—Varenicline—nicotine dependence	0.000548	0.0137	CcSEcCtD
Thioridazine—Rash—Varenicline—nicotine dependence	0.000544	0.0136	CcSEcCtD
Thioridazine—Dermatitis—Varenicline—nicotine dependence	0.000543	0.0136	CcSEcCtD
Thioridazine—Headache—Varenicline—nicotine dependence	0.00054	0.0135	CcSEcCtD
Thioridazine—Acepromazine—DRD2—nicotine dependence	0.000521	0.066	CrCbGaD
Thioridazine—Nausea—Varenicline—nicotine dependence	0.000512	0.0128	CcSEcCtD
Thioridazine—Thioproperazine—DRD2—nicotine dependence	0.00051	0.0645	CrCbGaD
Thioridazine—Thiothixene—DRD2—nicotine dependence	0.000501	0.0635	CrCbGaD
Thioridazine—Pipotiazine—DRD2—nicotine dependence	0.000501	0.0635	CrCbGaD
Thioridazine—HRH1—brain—nicotine dependence	0.000495	0.0166	CbGeAlD
Thioridazine—Mesoridazine—DRD2—nicotine dependence	0.000495	0.0626	CrCbGaD
Thioridazine—ADRA2A—brain—nicotine dependence	0.000486	0.0163	CbGeAlD
Thioridazine—Prochlorperazine—DRD2—nicotine dependence	0.000479	0.0607	CrCbGaD
Thioridazine—CYP2E1—brain—nicotine dependence	0.000476	0.0159	CbGeAlD
Thioridazine—Fluphenazine—DRD2—nicotine dependence	0.000433	0.0549	CrCbGaD
Thioridazine—Propiomazine—DRD2—nicotine dependence	0.000417	0.0528	CrCbGaD
Thioridazine—HTR2A—brain—nicotine dependence	0.000413	0.0139	CbGeAlD
Thioridazine—CYP2D6—brain—nicotine dependence	0.000377	0.0126	CbGeAlD
Thioridazine—Methotrimeprazine—DRD2—nicotine dependence	0.000356	0.0451	CrCbGaD
Thioridazine—Promethazine—DRD2—nicotine dependence	0.000351	0.0445	CrCbGaD
Thioridazine—Trifluoperazine—DRD2—nicotine dependence	0.000346	0.0439	CrCbGaD
Thioridazine—Perphenazine—DRD2—nicotine dependence	0.000343	0.0434	CrCbGaD
Thioridazine—Promazine—DRD2—nicotine dependence	0.000309	0.0391	CrCbGaD
Thioridazine—Chlorpromazine—DRD2—nicotine dependence	0.000272	0.0344	CrCbGaD
Thioridazine—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000251	0.00188	CbGpPWpGaD
Thioridazine—HTR6—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000246	0.00184	CbGpPWpGaD
Thioridazine—HTR7—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000246	0.00184	CbGpPWpGaD
Thioridazine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000245	0.00184	CbGpPWpGaD
Thioridazine—ADRA1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00024	0.0018	CbGpPWpGaD
Thioridazine—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000238	0.00179	CbGpPWpGaD
Thioridazine—HTR6—GPCR downstream signaling—FGD1—nicotine dependence	0.000234	0.00175	CbGpPWpGaD
Thioridazine—HTR7—GPCR downstream signaling—FGD1—nicotine dependence	0.000233	0.00175	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000233	0.00174	CbGpPWpGaD
Thioridazine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000231	0.00173	CbGpPWpGaD
Thioridazine—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00023	0.00173	CbGpPWpGaD
Thioridazine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000228	0.00171	CbGpPWpGaD
Thioridazine—HTR6—GPCR ligand binding—OPRM1—nicotine dependence	0.000222	0.00166	CbGpPWpGaD
Thioridazine—HTR7—GPCR ligand binding—OPRM1—nicotine dependence	0.000222	0.00166	CbGpPWpGaD
Thioridazine—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000221	0.00166	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00022	0.00165	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000219	0.00164	CbGpPWpGaD
Thioridazine—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000218	0.00163	CbGpPWpGaD
Thioridazine—HRH1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000217	0.00163	CbGpPWpGaD
Thioridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000216	0.00162	CbGpPWpGaD
Thioridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000215	0.00161	CbGpPWpGaD
Thioridazine—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000214	0.0016	CbGpPWpGaD
Thioridazine—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000213	0.0016	CbGpPWpGaD
Thioridazine—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000213	0.0016	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—FGD1—nicotine dependence	0.000212	0.00159	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—FGD1—nicotine dependence	0.000212	0.00159	CbGpPWpGaD
Thioridazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000212	0.00159	CbGpPWpGaD
Thioridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000211	0.00158	CbGpPWpGaD
Thioridazine—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000211	0.00158	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00021	0.00157	CbGpPWpGaD
Thioridazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000206	0.00154	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000201	0.00151	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.0002	0.0015	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000199	0.00149	CbGpPWpGaD
Thioridazine—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000198	0.00148	CbGpPWpGaD
Thioridazine—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000196	0.00147	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000193	0.00145	CbGpPWpGaD
Thioridazine—DRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.000191	0.00143	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000191	0.00143	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00019	0.00143	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00019	0.00142	CbGpPWpGaD
Thioridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000189	0.00142	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000187	0.0014	CbGpPWpGaD
Thioridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000186	0.0014	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000186	0.0014	CbGpPWpGaD
Thioridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000186	0.00139	CbGpPWpGaD
Thioridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000183	0.00137	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000183	0.00137	CbGpPWpGaD
Thioridazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000183	0.00137	CbGpPWpGaD
Thioridazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000182	0.00136	CbGpPWpGaD
Thioridazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000181	0.00136	CbGpPWpGaD
Thioridazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000181	0.00136	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000176	0.00132	CbGpPWpGaD
Thioridazine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000173	0.0013	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000173	0.0013	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000173	0.0013	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000173	0.0013	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000172	0.00129	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000172	0.00129	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00017	0.00127	CbGpPWpGaD
Thioridazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00017	0.00127	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000169	0.00127	CbGpPWpGaD
Thioridazine—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000166	0.00125	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000165	0.00123	CbGpPWpGaD
Thioridazine—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000164	0.00123	CbGpPWpGaD
Thioridazine—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000163	0.00123	CbGpPWpGaD
Thioridazine—HTR6—GPCR ligand binding—DRD2—nicotine dependence	0.000161	0.0012	CbGpPWpGaD
Thioridazine—HTR7—GPCR ligand binding—DRD2—nicotine dependence	0.00016	0.0012	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TAS2R16—nicotine dependence	0.00016	0.0012	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TAS2R16—nicotine dependence	0.000159	0.0012	CbGpPWpGaD
Thioridazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000157	0.00118	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000157	0.00118	CbGpPWpGaD
Thioridazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000157	0.00118	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000157	0.00118	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000157	0.00117	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000156	0.00117	CbGpPWpGaD
Thioridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000156	0.00117	CbGpPWpGaD
Thioridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000155	0.00116	CbGpPWpGaD
Thioridazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000154	0.00116	CbGpPWpGaD
Thioridazine—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000154	0.00116	CbGpPWpGaD
Thioridazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000154	0.00115	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000152	0.00114	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.00015	0.00112	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000149	0.00112	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.000149	0.00112	CbGpPWpGaD
Thioridazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000149	0.00111	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000147	0.0011	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000146	0.0011	CbGpPWpGaD
Thioridazine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000144	0.00108	CbGpPWpGaD
Thioridazine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000143	0.00107	CbGpPWpGaD
Thioridazine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000142	0.00106	CbGpPWpGaD
Thioridazine—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.000142	0.00106	CbGpPWpGaD
Thioridazine—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000139	0.00104	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000139	0.00104	CbGpPWpGaD
Thioridazine—DRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000138	0.00104	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000138	0.00103	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000137	0.00103	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000136	0.00102	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000136	0.00102	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.000135	0.00101	CbGpPWpGaD
Thioridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000135	0.00101	CbGpPWpGaD
Thioridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000135	0.00101	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000133	0.000998	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000133	0.000995	CbGpPWpGaD
Thioridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000132	0.000992	CbGpPWpGaD
Thioridazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000132	0.000989	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000129	0.000968	CbGpPWpGaD
Thioridazine—HTR6—GPCR downstream signaling—OPRM1—nicotine dependence	0.000125	0.00094	CbGpPWpGaD
Thioridazine—HTR7—GPCR downstream signaling—OPRM1—nicotine dependence	0.000125	0.000939	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—FGD1—nicotine dependence	0.000125	0.000939	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—FGD1—nicotine dependence	0.000125	0.000938	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.000123	0.000925	CbGpPWpGaD
Thioridazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000123	0.000919	CbGpPWpGaD
Thioridazine—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	0.000119	0.00089	CbGpPWpGaD
Thioridazine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.000118	0.000886	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000118	0.000886	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000118	0.000881	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—OPRM1—nicotine dependence	0.000114	0.000854	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—OPRM1—nicotine dependence	0.000114	0.000853	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	0.000113	0.000848	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000113	0.000844	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKR1B10—nicotine dependence	0.000111	0.000829	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKR1B10—nicotine dependence	0.000111	0.000828	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000108	0.000809	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—FGD1—nicotine dependence	0.000108	0.000808	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.000104	0.000778	CbGpPWpGaD
Thioridazine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000103	0.000769	CbGpPWpGaD
Thioridazine—HRH1—GPCR ligand binding—DRD2—nicotine dependence	0.000102	0.000768	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000102	0.000765	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	0.000102	0.000764	CbGpPWpGaD
Thioridazine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000101	0.000755	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000101	0.000753	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.0001	0.000751	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.0001	0.000749	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	9.81e-05	0.000735	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	9.53e-05	0.000714	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	9.34e-05	0.0007	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	9.29e-05	0.000696	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	9.29e-05	0.000696	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—FGD1—nicotine dependence	9.27e-05	0.000695	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	9.24e-05	0.000692	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	9.23e-05	0.000691	CbGpPWpGaD
Thioridazine—HTR6—GPCR downstream signaling—DRD2—nicotine dependence	9.07e-05	0.00068	CbGpPWpGaD
Thioridazine—HTR7—GPCR downstream signaling—DRD2—nicotine dependence	9.06e-05	0.000679	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	8.84e-05	0.000663	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	8.83e-05	0.000662	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	8.43e-05	0.000632	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	8.39e-05	0.000629	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—DRD2—nicotine dependence	8.24e-05	0.000617	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—DRD2—nicotine dependence	8.23e-05	0.000617	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	8.19e-05	0.000614	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	8.15e-05	0.000611	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	8.15e-05	0.000611	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—FGD1—nicotine dependence	8.14e-05	0.00061	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	8.03e-05	0.000602	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	8.02e-05	0.000601	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	8.01e-05	0.0006	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	8.01e-05	0.0006	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—FGD1—nicotine dependence	7.99e-05	0.000599	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	7.88e-05	0.00059	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	7.87e-05	0.00059	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	7.86e-05	0.000589	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	7.84e-05	0.000588	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	7.81e-05	0.000585	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	7.8e-05	0.000585	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—WASF2—nicotine dependence	7.8e-05	0.000584	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—WASF2—nicotine dependence	7.79e-05	0.000584	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—WASF1—nicotine dependence	7.48e-05	0.00056	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—WASF1—nicotine dependence	7.47e-05	0.00056	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	7.4e-05	0.000555	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	7.3e-05	0.000547	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	7.29e-05	0.000546	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	7.29e-05	0.000546	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	7.27e-05	0.000545	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	7.19e-05	0.000539	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—CYP2A7—nicotine dependence	7.16e-05	0.000536	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	7.15e-05	0.000536	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	7.13e-05	0.000535	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—DRD2—nicotine dependence	7.09e-05	0.000531	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	7.08e-05	0.00053	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	7.06e-05	0.000529	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	6.95e-05	0.000521	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	6.93e-05	0.000519	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—OPRM1—nicotine dependence	6.73e-05	0.000504	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—OPRM1—nicotine dependence	6.72e-05	0.000504	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	6.71e-05	0.000503	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—WASF2—nicotine dependence	6.71e-05	0.000503	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	6.68e-05	0.000501	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	6.63e-05	0.000497	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—CYP2A7—nicotine dependence	6.57e-05	0.000493	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	6.44e-05	0.000483	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—WASF1—nicotine dependence	6.43e-05	0.000482	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	6.39e-05	0.000479	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	6.1e-05	0.000457	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	6.07e-05	0.000455	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	5.81e-05	0.000435	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	5.8e-05	0.000435	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—OPRM1—nicotine dependence	5.79e-05	0.000434	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	5.79e-05	0.000434	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—WASF2—nicotine dependence	5.77e-05	0.000433	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	5.74e-05	0.00043	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	5.7e-05	0.000427	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CYP2A7—nicotine dependence	5.68e-05	0.000426	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	5.68e-05	0.000426	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—WASF1—nicotine dependence	5.53e-05	0.000415	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	5.5e-05	0.000413	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	5.5e-05	0.000412	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	5.28e-05	0.000396	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	5.27e-05	0.000395	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	5.27e-05	0.000395	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—DRD2—nicotine dependence	5.26e-05	0.000394	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	5.17e-05	0.000388	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	5.16e-05	0.000387	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CYP2A7—nicotine dependence	5.07e-05	0.00038	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—WASF2—nicotine dependence	5.07e-05	0.00038	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	4.99e-05	0.000374	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	4.98e-05	0.000373	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—WASF2—nicotine dependence	4.98e-05	0.000373	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	4.96e-05	0.000371	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	4.9e-05	0.000367	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	4.88e-05	0.000366	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—DRD2—nicotine dependence	4.87e-05	0.000365	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—DRD2—nicotine dependence	4.86e-05	0.000364	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—WASF1—nicotine dependence	4.86e-05	0.000364	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	4.79e-05	0.000359	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	4.78e-05	0.000358	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—WASF1—nicotine dependence	4.77e-05	0.000357	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	4.74e-05	0.000356	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	4.69e-05	0.000352	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	4.68e-05	0.000351	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	4.66e-05	0.00035	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CYP2A7—nicotine dependence	4.62e-05	0.000347	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	4.54e-05	0.00034	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	4.37e-05	0.000328	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	4.35e-05	0.000326	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	4.3e-05	0.000323	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—OPRM1—nicotine dependence	4.29e-05	0.000322	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	4.23e-05	0.000317	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	4.21e-05	0.000316	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—DRD2—nicotine dependence	4.19e-05	0.000314	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	3.95e-05	0.000296	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	3.92e-05	0.000293	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—DRD2—nicotine dependence	3.6e-05	0.00027	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	3.58e-05	0.000269	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	3.43e-05	0.000257	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	3.11e-05	0.000233	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—DRD2—nicotine dependence	3.11e-05	0.000233	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	3.06e-05	0.000229	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	3.05e-05	0.000228	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	2.83e-05	0.000212	CbGpPWpGaD
